Letter to the editor regarding "EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma".

Cancer letters Vol. 520 : 281 • Nov 2021

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 34384809

DOI: 10.1016/j.canlet.2021.07.042 [doi]

Publication Year: 2021

Language: e, n, g

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.